$344 Million is the total value of RTW INVESTMENTS, LP's 35 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 120.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALNY | Buy | Alnylam Pharmaceuticals Inc | $49,268,000 | +32.8% | 411,016 | +15.7% | 14.34% | -14.4% |
| BCRX | BioCryst Pharmaceuticals Inc | $33,762,000 | +65.3% | 2,261,361 | 0.0% | 9.83% | +6.6% | |
| KITE | Buy | Kite Pharma Inc | $24,388,000 | +12.6% | 400,000 | +6.5% | 7.10% | -27.4% |
| ACHN | Buy | Achillion Pharmaceuticals Inc | $22,287,000 | +39.3% | 2,515,433 | +55.0% | 6.49% | -10.2% |
| INCY | New | Incyte Corp | $20,321,000 | – | 195,000 | +100.0% | 5.92% | – |
| New | La Jolla Pharmaceutical Company Cmn Di | $19,131,000 | – | 780,547 | +100.0% | 5.57% | – | |
| ARWR | Buy | Arrowhead Research Corp | $18,304,000 | +12.3% | 2,560,000 | +6.2% | 5.33% | -27.6% |
| DRNA | Buy | Dicerna Pharmaceuticals Inc | $17,854,000 | -25.0% | 1,279,886 | +29.2% | 5.20% | -51.7% |
| AGEN | New | Agenus Inc | $17,717,000 | – | 2,052,915 | +100.0% | 5.16% | – |
| BLUE | Buy | bluebird bio Inc | $17,679,000 | +46.4% | 105,000 | +5.0% | 5.15% | -5.6% |
| DYAX | Sell | Dyax Corp | $14,817,000 | -44.2% | 559,141 | -64.7% | 4.31% | -64.0% |
| FPRX | New | Five Prime Therapeutics Inc | $13,921,000 | – | 560,437 | +100.0% | 4.05% | – |
| CLDX | New | Celldex Therapeutics Inc | $11,893,000 | – | 471,554 | +100.0% | 3.46% | – |
| TRGT | Targacept Inc | $7,437,000 | -6.1% | 2,665,643 | 0.0% | 2.16% | -39.4% | |
| LJPC | Sell | La Jolla Pharmaceutical Co | $6,953,000 | -64.3% | 283,700 | -73.3% | 2.02% | -77.0% |
| BMY | New | Bristol-Myers Squibb Co | $6,485,000 | – | 97,454 | +100.0% | 1.89% | – |
| SSRG | New | Symmetry Surgical Inc | $6,111,000 | – | 700,851 | +100.0% | 1.78% | – |
| New | Bristol Myers Squibb Co 01/15/2016 CALL 60call | $6,113,000 | – | 7,500 | +100.0% | 1.78% | – | |
| CORI | New | Corium International Inc | $4,860,000 | – | 355,007 | +100.0% | 1.42% | – |
| NLNK | New | NewLink Genetics Corp | $4,427,000 | – | 100,000 | +100.0% | 1.29% | – |
| TLT | New | iShares 20+ Year Treasury Bond ETF | $3,876,000 | – | 33,000 | +100.0% | 1.13% | – |
| USO | New | United States Oil ETF | $3,280,000 | – | 165,000 | +100.0% | 0.96% | – |
| LENS | Presbia Plc | $2,877,000 | +11.2% | 350,000 | 0.0% | 0.84% | -28.3% | |
| IVTY | New | Invuity Inc | $2,330,000 | – | 165,000 | +100.0% | 0.68% | – |
| LPCN | Lipocine Inc | $1,796,000 | +24.4% | 209,333 | 0.0% | 0.52% | -19.8% | |
| CYTR | Sell | CytRx Corp | $1,662,000 | -12.5% | 446,714 | -20.8% | 0.48% | -43.6% |
| RPRX | Repros Therapeutics Inc | $1,640,000 | -16.8% | 229,364 | 0.0% | 0.48% | -46.3% | |
| BPMX | New | Biopharmx Corp | $949,000 | – | 370,636 | +100.0% | 0.28% | – |
| NVLS | New | Nivalis Therapeutics Inc | $455,000 | – | 30,000 | +100.0% | 0.13% | – |
| ADAP | New | Adaptimmune Therapeutics-adr | $367,000 | – | 20,000 | +100.0% | 0.11% | – |
| New | Meridian Bioscience Inc. VIVO 10/16/2015 CALL 20call | $260,000 | – | 3,756 | +100.0% | 0.08% | – | |
| ZGNX | New | Zogenix Inc | $192,000 | – | 114,128 | +100.0% | 0.06% | – |
| New | Valeant Pharmaceuticals Intl VRX 10/16/2015 CALL 260call | $78,000 | – | 150 | +100.0% | 0.02% | – | |
| FBIO | New | Fortress Biotech Inc | $40,000 | – | 11,917 | +100.0% | 0.01% | – |
| BRKB | Berkshire Hathaway Inc | $7,000 | 0.0% | 50 | 0.0% | 0.00% | -33.3% | |
| TENX | Exit | Tenax Therapeutics Inc | $0 | – | -2,400 | -100.0% | -0.00% | – |
| SHAK | Exit | Shake Shack Inc | $0 | – | -500 | -100.0% | -0.01% | – |
| LPTN | Exit | Lpath Inc | $0 | – | -60,000 | -100.0% | -0.07% | – |
| RLYP | Exit | Relypsa Inc | $0 | – | -31,872 | -100.0% | -0.52% | – |
| TARO | Exit | Taro Pharmaceutical Industries Ltd | $0 | – | -8,721 | -100.0% | -0.56% | – |
| CNDO | Exit | Coronado Biosciences Inc | $0 | – | -500,000 | -100.0% | -0.87% | – |
| AAVL | Exit | Avalanche Biotechnologies In | $0 | – | -51,300 | -100.0% | -0.94% | – |
| ASMB | Exit | Assembly Biosciences Inc | $0 | – | -204,000 | -100.0% | -1.22% | – |
| ZSPH | Exit | ZS Pharma Inc | $0 | – | -71,315 | -100.0% | -1.36% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
| MASIMO CORP | 32 | Q3 2023 | 5.8% |
| LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
| REGENXBIO INC | 30 | Q4 2022 | 10.8% |
| AGENUS INC | 29 | Q2 2022 | 9.0% |
| PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
| DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
| MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
| ARGENX SE | 26 | Q3 2023 | 5.3% |
| VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
| ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
| Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
| Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.